These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35746614)

  • 1. Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo.
    Li Y; Liu M; Yan Y; Wang Z; Dai Q; Yang X; Guo X; Li W; Chen X; Cao R; Zhong W
    Viruses; 2022 May; 14(6):. PubMed ID: 35746614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
    Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
    J Virol; 2021 May; 95(12):. PubMed ID: 33789997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo.
    Cao Y; Lei E; Wang X; Qi X; Li L; Ren J; Yang J; Wang S
    Antiviral Res; 2021 Nov; 195():105091. PubMed ID: 34044060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
    Visser LJ; Langereis MA; Rabouw HH; Wahedi M; Muntjewerff EM; de Groot RJ; van Kuppeveld FJM
    J Virol; 2019 May; 93(10):. PubMed ID: 30867299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications.
    Sun J; Yogarajah T; Lee RCH; Kaur P; Inoue M; Tan YW; Chu JJH
    Sci Rep; 2020 May; 10(1):8159. PubMed ID: 32424333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Enterovirus A71 Infection and Antiviral Agents.
    Wei Y; Liu H; Hu D; He Q; Yao C; Li H; Hu K; Wang J
    Lab Invest; 2024 Feb; 104(2):100298. PubMed ID: 38008182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice.
    Lalani S; Tan SH; Tan KO; Lim HX; Ong KC; Wong KT; Poh CL
    Life Sci; 2021 Dec; 287():120097. PubMed ID: 34715144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pyrimidine Analog FNC Potently Inhibits the Replication of Multiple Enteroviruses.
    Xu N; Yang J; Zheng B; Zhang Y; Cao Y; Huan C; Wang S; Chang J; Zhang W
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.
    Ho JY; Chern JH; Hsieh CF; Liu ST; Liu CJ; Wang YS; Kuo TW; Hsu SJ; Yeh TK; Shih SR; Hsieh PW; Chiu CH; Horng JT
    J Antimicrob Chemother; 2016 Jul; 71(7):1922-32. PubMed ID: 27098012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: In vitro, in vivo, and combination therapy study.
    Tang Q; Xu Z; Jin M; Shu T; Chen Y; Feng L; Zhang Q; Lan K; Wu S; Zhou HB
    Eur J Med Chem; 2020 Sep; 202():112310. PubMed ID: 32619885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect in association with anti-apoptosis and anti-autophagy of repurposing formoterol fumarate dihydrate on enterovirus A71-infected neuronal cells.
    Jintana K; Prasertsopon J; Puthavathana P; Lerdsamran H
    Virus Res; 2022 Apr; 311():198692. PubMed ID: 35093474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Activity of
    Olasunkanmi OI; Fei Y; Avala Ntsigouaye J; Yi M; Wang Y; Liu J; Cheng W; Megeto J; Bashir T; Chen Y; Xu W; Lin L; Zhao W; Wang Y; Zhong Z
    Antimicrob Agents Chemother; 2023 Mar; 67(3):e0086822. PubMed ID: 36786598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative.
    Ibba R; Carta A; Madeddu S; Caria P; Serreli G; Piras S; Sestito S; Loddo R; Sanna G
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33406781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of broad-spectrum enterovirus antivirals based on quinoline scaffold.
    Musharrafieh R; Kitamura N; Hu Y; Wang J
    Bioorg Chem; 2020 Aug; 101():103981. PubMed ID: 32559580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molnupiravir: A new candidate for COVID-19 treatment.
    Pourkarim F; Pourtaghi-Anvarian S; Rezaee H
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00909. PubMed ID: 34968008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Disease States on the Oral Pharmacokinetics of EIDD-1931 (an Active Form of Molnupiravir) in Rats for Implication in the Dose Adjustment.
    Bhardwaj M; Gour A; Ahmed A; Dhiman S; Manhas D; Khajuria P; Wazir P; Mukherjee D; Nandi U
    Mol Pharm; 2023 Sep; 20(9):4597-4610. PubMed ID: 37527414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of G-Quadruplexes in Enterovirus A71 Genome and Their Interaction with G-Quadruplex Ligands.
    Lv L; Zhang L
    Microbiol Spectr; 2022 Jun; 10(3):e0046022. PubMed ID: 35446122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molnupiravir for the treatment of COVID-19.
    Santani BG; LeBlanc BW; Thakare RP
    Drugs Today (Barc); 2022 Jul; 58(7):335-350. PubMed ID: 35851869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.
    Ianevski A; Frøysa IT; Lysvand H; Calitz C; Smura T; Schjelderup Nilsen HJ; Høyer E; Afset JE; Sridhar A; Wolthers KC; Zusinaite E; Tenson T; Kurg R; Oksenych V; Galabov AS; Stoyanova A; Bjørås M; Kainov DE
    Antiviral Res; 2024 Apr; 224():105842. PubMed ID: 38417531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice.
    Lee MHP; Tan CW; Tee HK; Ong KC; Sam IC; Chan YF
    Vaccine; 2021 Mar; 39(12):1708-1720. PubMed ID: 33640144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.